Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
80.46
+3.59 (4.67%)
At close: Mar 9, 2026, 4:00 PM EDT
78.86
-1.60 (-1.99%)
After-hours: Mar 9, 2026, 7:06 PM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $793.06 million as of March 9, 2026. Its market cap has increased by 240.16% in one year.
Market Cap
793.06M
Enterprise Value
727.51M
1-Year Change
240.16%
Ranking
Category
Stock Price
$80.46
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $793.06M, an increase of 1,798.04%. That is a compound annual growth rate of 78.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 793.06M | 26.45% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MapLight Therapeutics | 807.80M |
| MannKind | 804.14M |
| CytomX Therapeutics | 792.96M |
| Kura Oncology | 791.43M |
| Eikon Therapeutics | 776.29M |
| Annexon | 769.13M |
| Lexicon Pharmaceuticals | 730.31M |
| Prime Medicine | 710.09M |